Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1262Source: DataRank Database

The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0. It has been cited 57 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access57 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.67)OA: bronzeTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Marcia N. Paddock ORCID,Haibin Wang ORCID,Charles J. Murphy ORCID,Renee C. Geck ORCID,Adrija J. Navarro

Live enrichment

PubMed:32513774 PMC:PMC7415683 OpenAlex:https://openalex.org/W3034026561

Deutsche Forschungsgemeinschaft

Grant: TRR186/A08

NIH

Grant: R35 CA197588

NIH

Grant: R01 CA226776

NIH

Grant: U54CA210184

NCI

Grant: F31 CA213460

NCI NIH HHS

Grant: R01 CA200671

NCI NIH HHS

Grant: R01 CA177910

NCI NIH HHS

Grant: R35 CA253097

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

FWCI

2.67

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronze

journalhttps://aacrjournals.org/cancerdiscovery/article-pdf/10/8/1226/1814650/1226.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/10/8/1226/1814650/1226.pdf

journalhttps://doi.org/10.1158/2159-8290.cd-19-1262

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32513774

repositoryhttp://europepmc.org/pmc/articles/PMC7415683

Fields of Study

Cancer-related Molecular PathwaysAdvanced Breast Cancer TherapiesPI3K/AKT/mTOR signaling in cancer0301 basic medicine03 medical and health sciencesAnimalsAntineoplastic AgentsCells, CulturedDisease Models, AnimalGenes, Tumor SuppressorHumansMice, TransgenicPhosphatidylinositolsPhosphoric Monoester HydrolasesProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesSignal TransductionTriple Negative Breast Neoplasms

MeSH Terms

AnimalsAntineoplastic AgentsCells, CulturedDisease Models, AnimalHumansMice, TransgenicPhosphatidylinositolsPhosphoric Monoester HydrolasesSignal TransductionGenes, Tumor SuppressorReceptor Protein-Tyrosine KinasesProtein Kinase InhibitorsTriple Negative Breast Neoplasms

Keywords

SuppressorTriple-negative breast cancerCancer researchBreast cancerCancerMedicineBiologyInternal medicineReceptor Protein-Tyrosine KinasesAntineoplastic AgentsMice, TransgenicTriple Negative Breast NeoplasmsPhosphatidylinositolsPhosphoric Monoester HydrolasesDisease Models, AnimalAnimalsHumansGenes, Tumor SuppressorProtein Kinase InhibitorsCells, CulturedSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer

FAIR Checklist

Authors (11)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)